What Is BPC-157? Dosage, Half-Life & How to Track It

What BPC-157 is and how it works

BPC-157 stands for Body Protection Compound-157, a lab-made chain of 15 amino acids modeled on a fragment of a protein your own stomach produces. The name is the whole story: it was first studied for its protective, healing effect on the gut lining, and later for connective tissue more broadly.

The interesting part of the mechanism is that it recruits your body’s own repair machinery rather than acting like a hormone. Preclinical work points to it upregulating VEGF (a signal that drives new blood-vessel growth), engaging the FAK-paxillin pathway that helps fibroblasts migrate and rebuild tissue, and interacting with the nitric-oxide system to improve blood flow at a damaged site. The practical read: it tends to act locally, near where it is injected — which is why people often pin it close to the area they care about.

Worth being straight about the evidence: the healing results are overwhelmingly from animal and test-tube studies. Human clinical data is thin, and it is not FDA-approved for human use. Treat the mechanism as promising and the dosing as community-derived, not settled medicine.

Typical dosing & reconstitution

BPC-157 comes as a lyophilized (freeze-dried) powder that you reconstitute with bacteriostatic water before drawing anything up. A typical daily range is 200–600 mcg subcutaneously, usually started low and titrated over the first few weeks. Because it can’t form a depot in the tissue the way an oiled testosterone ester does, single infrequent doses don’t buy you anything — daily is the point.

How much BAC water you add sets your concentration, and your concentration sets how many syringe units a dose is. Two common setups:

At 1.67 mg/mL, a 300 mcg dose is 18 units on a standard U-100 insulin syringe. Add more water and each unit carries less peptide, which makes small doses easier to measure accurately — the trade-off the reconstitution math exists to manage.

Half-life & what it means for frequency

BPC-157 clears fast — its half-life is on the order of 30 minutes, after which it is metabolized in the liver and cleared by the kidneys. That short window is the entire reason the standard schedule is once (sometimes twice) daily rather than a weekly shot.

It also means timing is forgiving: there is no long tail to accumulate from day to day, so a missed dose doesn’t linger and a slightly early one doesn’t pile up. Some people split the daily amount into a morning and evening pin when they want steadier exposure across the day, but that is a preference, not a requirement.

What to track & common side effects

BPC-157 is generally reported as well tolerated, with a notably clean side-effect profile in the studies that exist. The most common real-world complaints are local — injection-site irritation, redness, or occasional lightheadedness.

Two cautions worth holding onto. First, because it is pro-angiogenic (it encourages new blood vessels), an active or recent cancer history is a standard reason to talk to a doctor before touching it. Second, product quality varies by source. What is genuinely worth tracking is simpler: the injury or symptom you are actually targeting, dose and site each day, and whether the trend is moving — exactly the kind of thing that is easy to lose track of from memory.

Frequently asked questions